Intra Cellular Therapies | ITCI - Loan Capital

Intra Cellular Therapies reported $0 in Loan Capital for its second fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

API Features Documentation Interested? Click here to contact us
Please Paste this Code in your Website
width
height
 Preview
Loan Capital Change
ALKERMES ALKS:US USD 290.27M 634K
Aptinyx Inc APTX:US USD 24.71M 211K
Biogen BIIB:US USD 6.28B 1.8M
Cytokinetics CYTK:US USD 610.62M 888K
Esperion Therapeutics ESPR:US USD 259.9M 412K
Halozyme Therapeutics HALO:US USD 1.49B 1.61M
JAZZ PHA JAZZ:US USD 5.69B 2.47M
Marinus Pharmaceuticals MRNS:US USD 71.02M 238K
Novartis NVS:US USD 21.78B 547M
United Therapeutics UTHR:US USD 800M 0